Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) Using Fibroblasts Transfected With DNA From Autologous Tumor (Phase IB Study)

NCT00793208 is registered in ClinicalTrials.gov with Theresa Whiteside, PhD as lead sponsor.

NCT NCT00793208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00793208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) Using Fibroblasts Transfected With DNA From Autologous Tumor (Phase IB Study)
Lead sponsor
Theresa Whiteside, PhD
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2008
Completion date
November 30, 2015
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer (nsclc)